vTv Therapeutics's market cap is currently ―. The company's EPS TTM is $-8.867; its P/E ratio is -2.63; vTv Therapeutics is scheduled to report earnings on July 31, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Income Statement	-
Total Revenue	$ 1.00M	-	-	-	-
Gross Profit	$ 1.00M	-	-	-	-
EBIT	$ -5.55M	$ -4.43M	$ -8.54M	$ -7.21M	$ -5.87M
EBITDA	$ -5.53M	$ -4.41M	-	$ -7.19M	$ -5.85M
Net Income Common Stockholders	$ -4.87M	$ -3.48M	$ -6.65M	$ -5.62M	$ -4.50M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 52.26M	$ 9.45M	$ 8.24M	$ 12.60M	$ 18.78M
Total Assets	$ 54.18M	$ 11.02M	$ 14.92M	$ 22.43M	$ 28.64M
Total Debt	$ 298.00K	$ 529.00K	$ 851.00K	$ 417.00K	$ 454.00K
Net Debt	$ -51.96M	$ -8.92M	$ -7.39M	$ -12.18M	$ -18.33M
Total Liabilities	$ 28.20M	$ 29.57M	$ 29.43M	$ 28.83M	$ 28.42M
Stockholders Equity	$ 20.80M	$ -24.68M	$ -25.23M	$ -25.28M	$ -19.42M
Cash Flow	-
Free Cash Flow	$ -7.33M	$ -2.91M	-	$ -6.17M	$ -5.17M
Operating Cash Flow	$ -7.33M	$ -2.91M	$ -4.83M	$ -6.17M	$ -5.17M
Investing Cash Flow	-	$ 4.40M	-	-	-
Financing Cash Flow	$ 50.14M	$ -282.00K	$ 473.00K	-	$ 11.81M

Currency in USD

vTv Therapeutics Earnings and Revenue History

Income Statement >

vTv Therapeutics Debt to Assets

Balance Sheet >

vTv Therapeutics Cash Flow

Cash Flow >

vTv Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing